Q08698--P9WH75--72.9--0.0--nrdE Rv3051c MTV012.66c--Genetic information processing; DNA replication. --FUNCTION: Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides. When coexpressed in E.coli with nrdF2 the 2 proteins complement a temperature-sensitive E.coli mutant, however coexpression with nrdF1 does not complement. {ECO:0000269|PubMed:9335290}.--CATALYTIC ACTIVITY: Reaction=[thioredoxin]-disulfide + a 2'-deoxyribonucleoside 5'-diphosphate + H2O = [thioredoxin]-dithiol + a ribonucleoside 5'-diphosphate; Xref=Rhea:RHEA:23252, Rhea:RHEA-COMP:10698, Rhea:RHEA-COMP:10700, ChEBI:CHEBI:15377, ChEBI:CHEBI:29950, ChEBI:CHEBI:50058, ChEBI:CHEBI:57930, ChEBI:CHEBI:73316; EC=1.17.4.1; Evidence={ECO:0000269|PubMed:9335290};--   --
Q9CBQ2--P9WH71--93.5--0.0--nrdF2 Rv3048c--Genetic information processing; DNA replication. --FUNCTION: Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides. Two genes for this protein are present in M.tuberculosis; this is the active form. When coexpressed in E.coli with nrdE the 2 proteins complement a temperature-sensitive E.coli mutant. {ECO:0000269|PubMed:9335290}.--CATALYTIC ACTIVITY: Reaction=[thioredoxin]-disulfide + a 2'-deoxyribonucleoside 5'-diphosphate + H2O = [thioredoxin]-dithiol + a ribonucleoside 5'-diphosphate; Xref=Rhea:RHEA:23252, Rhea:RHEA-COMP:10698, Rhea:RHEA-COMP:10700, ChEBI:CHEBI:15377, ChEBI:CHEBI:29950, ChEBI:CHEBI:50058, ChEBI:CHEBI:57930, ChEBI:CHEBI:73316; EC=1.17.4.1; Evidence={ECO:0000255|PROSITE-ProRule:PRU10014, ECO:0000269|PubMed:9335290};--   --1UZR;
Q9CBQ2--P9WH73--71.2--1.6E-166--nrdF1 Rv1981c MTCY39.38--Genetic information processing; DNA replication. --FUNCTION: Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides (By similarity). Two genes for this protein are present in M.tuberculosis; this is thought to not be the active form. When coexpressed in E.coli with nrdE the 2 proteins do not complement a temperature-sensitive E.coli mutant, whereas the other gene (nrdF2) does complement. {ECO:0000250}.--CATALYTIC ACTIVITY: Reaction=[thioredoxin]-disulfide + a 2'-deoxyribonucleoside 5'-diphosphate + H2O = [thioredoxin]-dithiol + a ribonucleoside 5'-diphosphate; Xref=Rhea:RHEA:23252, Rhea:RHEA-COMP:10698, Rhea:RHEA-COMP:10700, ChEBI:CHEBI:15377, ChEBI:CHEBI:29950, ChEBI:CHEBI:50058, ChEBI:CHEBI:57930, ChEBI:CHEBI:73316; EC=1.17.4.1; Evidence={ECO:0000255|PROSITE-ProRule:PRU10014};--   --
P9WIQ3--P9WIQ3--100.0--0.0--fprA Rv3106 MTCY164.16----FUNCTION: May serve as electron transfer protein and supply electrons to P450 systems.--CATALYTIC ACTIVITY: Reaction=H(+) + NADP(+) + 2 reduced [2Fe-2S]-[ferredoxin] = NADPH + 2 oxidized [2Fe-2S]-[ferredoxin]; Xref=Rhea:RHEA:20125, Rhea:RHEA-COMP:10000, Rhea:RHEA-COMP:10001, ChEBI:CHEBI:15378, ChEBI:CHEBI:33737, ChEBI:CHEBI:33738, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.18.1.2;--   --1LQT;1LQU;2C7G;
P9WIQ3--P9WJI1--41.2--0.0--0.0--0.0--0.0--0.0--0.0--0.0
P9WPB7--P9WPB7--100.0--0.0--cmaA1 cma1 CMAS-1 Rv3392c MTV004.50--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Catalyzes the conversion of a double bond to a cyclopropane ring at the distal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:7592990}.--CATALYTIC ACTIVITY: Reaction=1-acyl-2-(9Z)-enoyl-sn-glycero-3-phospholipid + S-adenosyl-L-methionine = 1-acyl-2-(9-cyclopronane)-acyl-sn-glycero-3-phospholipid + H(+) + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:11988, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:76593, ChEBI:CHEBI:76594; EC=2.1.1.79;--   --1KP9;1KPG;1KPH;
P9WPB7--Q79FX6--73.5--2.2E-155--mmaA2 mma2 Rv0644c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Catalyzes the conversion of a double bond to a cis cyclopropane ring at the distal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. MmaA2 also catalyzes the biosynthesis of the cis-cyclopropanated methoxymycolates. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:12502719, ECO:0000269|PubMed:20472794}.--CATALYTIC ACTIVITY: Reaction=1-acyl-2-(9Z)-enoyl-sn-glycero-3-phospholipid + S-adenosyl-L-methionine = 1-acyl-2-(9-cyclopronane)-acyl-sn-glycero-3-phospholipid + H(+) + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:11988, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:76593, ChEBI:CHEBI:76594; EC=2.1.1.79;--   --1TPY;
P9WPB7--P9WPB3--72.8--9.6E-150--pcaA cma3 cmaA3 CMAS-3 Rv0470c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Involved in the phagosome maturation block (PMB). Catalyzes the conversion of a double bond to a cyclopropane ring at the proximal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. It can use cis, cis 11,14-eicosadienoic acid and linoelaidic acid as substrate. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:10882107, ECO:0000269|PubMed:22621931}.--CATALYTIC ACTIVITY: Reaction=1-acyl-2-(9Z)-enoyl-sn-glycero-3-phospholipid + S-adenosyl-L-methionine = 1-acyl-2-(9-cyclopronane)-acyl-sn-glycero-3-phospholipid + H(+) + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:11988, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:76593, ChEBI:CHEBI:76594; EC=2.1.1.79; Evidence={ECO:0000269|PubMed:22621931};--   --1L1E;
P9WPB7--P0CH91--68.6--3.8E-139--mmaA3 mma3 Rv0643c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Involved in the biosynthesis of methoxymycolic acid. It catalyzes the O-methylation of the hydroxy group of the hydroxymycolate to form a methyl ether. {ECO:0000269|PubMed:10852869, ECO:0000269|PubMed:9781881}.----   --
P9WPB7--Q79FX8--58.7--9.0E-116--mmaA4 hma mma4 Rv0642c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Involved in the biosynthesis of hydroxymycolate, a common precursor of oxygenated mycolic acids (methoxy-mycolate and keto-mycolate). Probably transfers a methyl group from the S-adenosylmethionine (SAM) cofactor and, subsequently or simultaneously, a water molecule onto the double bound of ethylene substrates, leading to the formation of the hydroxylated product at the distal position. Involved in the activation of the antitubercular drug thiacetazone (TAC). {ECO:0000269|PubMed:10844652, ECO:0000269|PubMed:12473649}.----   --2FK7;2FK8;3HA3;3HA5;3HA7;
P9WPB7--P9WPB1--57.0--4.5E-110--mmaA1 mma1 Rv0645c MTCY20H10.26c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Involved in the conversion of a cis-olefin into a trans-olefin with concomitant introduction of an allylic methyl branch at the proximal position of the precursor to both the methoxy and ketomycolic acids. It directly affects the cis- to trans ratio and indirectly affects the keto to methoxy ratio. {ECO:0000269|PubMed:20472794, ECO:0000269|PubMed:9092547}.----   --
P9WPB7--Q6MX39--56.7--6.4E-110--umaA Rv0469 LH57_02505----FUNCTION: Methyltransferase that modifies short-chain fatty acids. In vitro, catalyzes the transfer of the methyl group from S-adenosyl-L-methionine (SAM) to the double bond of phospholipid-linked oleic acid to produce tuberculostearic acid (10-methylstearic-acid or TSA). {ECO:0000269|PubMed:23435098}.----   --
P9WPB7--P9WPB5--55.7--3.4E-106--cmaA2 cma2 CMAS-2 Rv0503c MTCY20G9.30c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Catalyzes the formation of trans cyclopropanated ketomycolate or methoxymycolate through the conversion of a double bond to a cyclopropane ring at the proximal position of an oxygenated mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. In the absence of MmaA2, CmaA2 has a non-specific cis-cyclopropanating activity and is able to catalyze the conversion of a double bond to a cis cyclopropane ring at the distal position of an alpha mycolic acid. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:11092877, ECO:0000269|PubMed:7592990}.--CATALYTIC ACTIVITY: Reaction=1-acyl-2-(9Z)-enoyl-sn-glycero-3-phospholipid + S-adenosyl-L-methionine = 1-acyl-2-(9-cyclopronane)-acyl-sn-glycero-3-phospholipid + H(+) + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:11988, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:76593, ChEBI:CHEBI:76594; EC=2.1.1.79;--   --1KPI;3HEM;
P9WPB5--P9WPB5--100.0--0.0--cmaA2 cma2 CMAS-2 Rv0503c MTCY20G9.30c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Catalyzes the formation of trans cyclopropanated ketomycolate or methoxymycolate through the conversion of a double bond to a cyclopropane ring at the proximal position of an oxygenated mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. In the absence of MmaA2, CmaA2 has a non-specific cis-cyclopropanating activity and is able to catalyze the conversion of a double bond to a cis cyclopropane ring at the distal position of an alpha mycolic acid. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:11092877, ECO:0000269|PubMed:7592990}.--CATALYTIC ACTIVITY: Reaction=1-acyl-2-(9Z)-enoyl-sn-glycero-3-phospholipid + S-adenosyl-L-methionine = 1-acyl-2-(9-cyclopronane)-acyl-sn-glycero-3-phospholipid + H(+) + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:11988, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:76593, ChEBI:CHEBI:76594; EC=2.1.1.79;--   --1KPI;3HEM;
P9WPB5--P9WPB3--58.4--2.0E-115--pcaA cma3 cmaA3 CMAS-3 Rv0470c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Involved in the phagosome maturation block (PMB). Catalyzes the conversion of a double bond to a cyclopropane ring at the proximal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. It can use cis, cis 11,14-eicosadienoic acid and linoelaidic acid as substrate. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:10882107, ECO:0000269|PubMed:22621931}.--CATALYTIC ACTIVITY: Reaction=1-acyl-2-(9Z)-enoyl-sn-glycero-3-phospholipid + S-adenosyl-L-methionine = 1-acyl-2-(9-cyclopronane)-acyl-sn-glycero-3-phospholipid + H(+) + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:11988, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:76593, ChEBI:CHEBI:76594; EC=2.1.1.79; Evidence={ECO:0000269|PubMed:22621931};--   --1L1E;
P9WPB5--Q79FX6--55.9--8.1E-110--mmaA2 mma2 Rv0644c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Catalyzes the conversion of a double bond to a cis cyclopropane ring at the distal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. MmaA2 also catalyzes the biosynthesis of the cis-cyclopropanated methoxymycolates. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:12502719, ECO:0000269|PubMed:20472794}.--CATALYTIC ACTIVITY: Reaction=1-acyl-2-(9Z)-enoyl-sn-glycero-3-phospholipid + S-adenosyl-L-methionine = 1-acyl-2-(9-cyclopronane)-acyl-sn-glycero-3-phospholipid + H(+) + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:11988, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:76593, ChEBI:CHEBI:76594; EC=2.1.1.79;--   --1TPY;
P9WPB5--P9WPB7--55.7--3.6E-106--cmaA1 cma1 CMAS-1 Rv3392c MTV004.50--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Catalyzes the conversion of a double bond to a cyclopropane ring at the distal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:7592990}.--CATALYTIC ACTIVITY: Reaction=1-acyl-2-(9Z)-enoyl-sn-glycero-3-phospholipid + S-adenosyl-L-methionine = 1-acyl-2-(9-cyclopronane)-acyl-sn-glycero-3-phospholipid + H(+) + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:11988, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:76593, ChEBI:CHEBI:76594; EC=2.1.1.79;--   --1KP9;1KPG;1KPH;
P9WPB5--Q6MX39--53.4--5.3E-103--umaA Rv0469 LH57_02505----FUNCTION: Methyltransferase that modifies short-chain fatty acids. In vitro, catalyzes the transfer of the methyl group from S-adenosyl-L-methionine (SAM) to the double bond of phospholipid-linked oleic acid to produce tuberculostearic acid (10-methylstearic-acid or TSA). {ECO:0000269|PubMed:23435098}.----   --
P9WPB5--P0CH91--51.9--7.7E-102--mmaA3 mma3 Rv0643c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Involved in the biosynthesis of methoxymycolic acid. It catalyzes the O-methylation of the hydroxy group of the hydroxymycolate to form a methyl ether. {ECO:0000269|PubMed:10852869, ECO:0000269|PubMed:9781881}.----   --
P9WPB5--P9WPB1--51.5--1.2E-96--mmaA1 mma1 Rv0645c MTCY20H10.26c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Involved in the conversion of a cis-olefin into a trans-olefin with concomitant introduction of an allylic methyl branch at the proximal position of the precursor to both the methoxy and ketomycolic acids. It directly affects the cis- to trans ratio and indirectly affects the keto to methoxy ratio. {ECO:0000269|PubMed:20472794, ECO:0000269|PubMed:9092547}.----   --
P9WPB5--Q79FX8--50.0--1.2E-95--mmaA4 hma mma4 Rv0642c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Involved in the biosynthesis of hydroxymycolate, a common precursor of oxygenated mycolic acids (methoxy-mycolate and keto-mycolate). Probably transfers a methyl group from the S-adenosylmethionine (SAM) cofactor and, subsequently or simultaneously, a water molecule onto the double bound of ethylene substrates, leading to the formation of the hydroxylated product at the distal position. Involved in the activation of the antitubercular drug thiacetazone (TAC). {ECO:0000269|PubMed:10844652, ECO:0000269|PubMed:12473649}.----   --2FK7;2FK8;3HA3;3HA5;3HA7;
P9WPB3--P9WPB3--100.0--0.0--pcaA cma3 cmaA3 CMAS-3 Rv0470c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Involved in the phagosome maturation block (PMB). Catalyzes the conversion of a double bond to a cyclopropane ring at the proximal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. It can use cis, cis 11,14-eicosadienoic acid and linoelaidic acid as substrate. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:10882107, ECO:0000269|PubMed:22621931}.--CATALYTIC ACTIVITY: Reaction=1-acyl-2-(9Z)-enoyl-sn-glycero-3-phospholipid + S-adenosyl-L-methionine = 1-acyl-2-(9-cyclopronane)-acyl-sn-glycero-3-phospholipid + H(+) + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:11988, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:76593, ChEBI:CHEBI:76594; EC=2.1.1.79; Evidence={ECO:0000269|PubMed:22621931};--   --1L1E;
P9WPB3--P9WPB7--72.8--9.6E-150--cmaA1 cma1 CMAS-1 Rv3392c MTV004.50--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Catalyzes the conversion of a double bond to a cyclopropane ring at the distal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:7592990}.--CATALYTIC ACTIVITY: Reaction=1-acyl-2-(9Z)-enoyl-sn-glycero-3-phospholipid + S-adenosyl-L-methionine = 1-acyl-2-(9-cyclopronane)-acyl-sn-glycero-3-phospholipid + H(+) + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:11988, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:76593, ChEBI:CHEBI:76594; EC=2.1.1.79;--   --1KP9;1KPG;1KPH;
P9WPB3--Q79FX6--73.1--4.3E-146--mmaA2 mma2 Rv0644c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Catalyzes the conversion of a double bond to a cis cyclopropane ring at the distal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. MmaA2 also catalyzes the biosynthesis of the cis-cyclopropanated methoxymycolates. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:12502719, ECO:0000269|PubMed:20472794}.--CATALYTIC ACTIVITY: Reaction=1-acyl-2-(9Z)-enoyl-sn-glycero-3-phospholipid + S-adenosyl-L-methionine = 1-acyl-2-(9-cyclopronane)-acyl-sn-glycero-3-phospholipid + H(+) + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:11988, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:76593, ChEBI:CHEBI:76594; EC=2.1.1.79;--   --1TPY;
P9WPB3--P0CH91--64.3--5.8E-129--mmaA3 mma3 Rv0643c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Involved in the biosynthesis of methoxymycolic acid. It catalyzes the O-methylation of the hydroxy group of the hydroxymycolate to form a methyl ether. {ECO:0000269|PubMed:10852869, ECO:0000269|PubMed:9781881}.----   --
P9WPB3--P9WPB5--58.4--1.9E-115--cmaA2 cma2 CMAS-2 Rv0503c MTCY20G9.30c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Catalyzes the formation of trans cyclopropanated ketomycolate or methoxymycolate through the conversion of a double bond to a cyclopropane ring at the proximal position of an oxygenated mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. In the absence of MmaA2, CmaA2 has a non-specific cis-cyclopropanating activity and is able to catalyze the conversion of a double bond to a cis cyclopropane ring at the distal position of an alpha mycolic acid. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:11092877, ECO:0000269|PubMed:7592990}.--CATALYTIC ACTIVITY: Reaction=1-acyl-2-(9Z)-enoyl-sn-glycero-3-phospholipid + S-adenosyl-L-methionine = 1-acyl-2-(9-cyclopronane)-acyl-sn-glycero-3-phospholipid + H(+) + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:11988, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:76593, ChEBI:CHEBI:76594; EC=2.1.1.79;--   --1KPI;3HEM;
P9WPB3--Q6MX39--57.4--6.4E-110--umaA Rv0469 LH57_02505----FUNCTION: Methyltransferase that modifies short-chain fatty acids. In vitro, catalyzes the transfer of the methyl group from S-adenosyl-L-methionine (SAM) to the double bond of phospholipid-linked oleic acid to produce tuberculostearic acid (10-methylstearic-acid or TSA). {ECO:0000269|PubMed:23435098}.----   --
P9WPB3--P9WPB1--54.6--4.6E-105--mmaA1 mma1 Rv0645c MTCY20H10.26c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Involved in the conversion of a cis-olefin into a trans-olefin with concomitant introduction of an allylic methyl branch at the proximal position of the precursor to both the methoxy and ketomycolic acids. It directly affects the cis- to trans ratio and indirectly affects the keto to methoxy ratio. {ECO:0000269|PubMed:20472794, ECO:0000269|PubMed:9092547}.----   --
P9WPB3--Q79FX8--55.6--7.6E-105--mmaA4 hma mma4 Rv0642c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Involved in the biosynthesis of hydroxymycolate, a common precursor of oxygenated mycolic acids (methoxy-mycolate and keto-mycolate). Probably transfers a methyl group from the S-adenosylmethionine (SAM) cofactor and, subsequently or simultaneously, a water molecule onto the double bound of ethylene substrates, leading to the formation of the hydroxylated product at the distal position. Involved in the activation of the antitubercular drug thiacetazone (TAC). {ECO:0000269|PubMed:10844652, ECO:0000269|PubMed:12473649}.----   --2FK7;2FK8;3HA3;3HA5;3HA7;
Q79FX6--Q79FX6--100.0--0.0--mmaA2 mma2 Rv0644c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Catalyzes the conversion of a double bond to a cis cyclopropane ring at the distal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. MmaA2 also catalyzes the biosynthesis of the cis-cyclopropanated methoxymycolates. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:12502719, ECO:0000269|PubMed:20472794}.--CATALYTIC ACTIVITY: Reaction=1-acyl-2-(9Z)-enoyl-sn-glycero-3-phospholipid + S-adenosyl-L-methionine = 1-acyl-2-(9-cyclopronane)-acyl-sn-glycero-3-phospholipid + H(+) + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:11988, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:76593, ChEBI:CHEBI:76594; EC=2.1.1.79;--   --1TPY;
Q79FX6--P9WPB7--73.5--2.2E-155--cmaA1 cma1 CMAS-1 Rv3392c MTV004.50--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Catalyzes the conversion of a double bond to a cyclopropane ring at the distal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:7592990}.--CATALYTIC ACTIVITY: Reaction=1-acyl-2-(9Z)-enoyl-sn-glycero-3-phospholipid + S-adenosyl-L-methionine = 1-acyl-2-(9-cyclopronane)-acyl-sn-glycero-3-phospholipid + H(+) + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:11988, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:76593, ChEBI:CHEBI:76594; EC=2.1.1.79;--   --1KP9;1KPG;1KPH;
Q79FX6--P9WPB3--73.1--4.3E-146--pcaA cma3 cmaA3 CMAS-3 Rv0470c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Involved in the phagosome maturation block (PMB). Catalyzes the conversion of a double bond to a cyclopropane ring at the proximal position of an alpha mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. It can use cis, cis 11,14-eicosadienoic acid and linoelaidic acid as substrate. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:10882107, ECO:0000269|PubMed:22621931}.--CATALYTIC ACTIVITY: Reaction=1-acyl-2-(9Z)-enoyl-sn-glycero-3-phospholipid + S-adenosyl-L-methionine = 1-acyl-2-(9-cyclopronane)-acyl-sn-glycero-3-phospholipid + H(+) + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:11988, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:76593, ChEBI:CHEBI:76594; EC=2.1.1.79; Evidence={ECO:0000269|PubMed:22621931};--   --1L1E;
Q79FX6--P0CH91--69.1--2.0E-141--mmaA3 mma3 Rv0643c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Involved in the biosynthesis of methoxymycolic acid. It catalyzes the O-methylation of the hydroxy group of the hydroxymycolate to form a methyl ether. {ECO:0000269|PubMed:10852869, ECO:0000269|PubMed:9781881}.----   --
Q79FX6--Q79FX8--57.0--7.5E-110--mmaA4 hma mma4 Rv0642c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Involved in the biosynthesis of hydroxymycolate, a common precursor of oxygenated mycolic acids (methoxy-mycolate and keto-mycolate). Probably transfers a methyl group from the S-adenosylmethionine (SAM) cofactor and, subsequently or simultaneously, a water molecule onto the double bound of ethylene substrates, leading to the formation of the hydroxylated product at the distal position. Involved in the activation of the antitubercular drug thiacetazone (TAC). {ECO:0000269|PubMed:10844652, ECO:0000269|PubMed:12473649}.----   --2FK7;2FK8;3HA3;3HA5;3HA7;
Q79FX6--P9WPB5--55.9--7.7E-110--cmaA2 cma2 CMAS-2 Rv0503c MTCY20G9.30c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Catalyzes the formation of trans cyclopropanated ketomycolate or methoxymycolate through the conversion of a double bond to a cyclopropane ring at the proximal position of an oxygenated mycolic acid via the transfer of a methylene group from S-adenosyl-L-methionine. In the absence of MmaA2, CmaA2 has a non-specific cis-cyclopropanating activity and is able to catalyze the conversion of a double bond to a cis cyclopropane ring at the distal position of an alpha mycolic acid. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence. {ECO:0000269|PubMed:11092877, ECO:0000269|PubMed:7592990}.--CATALYTIC ACTIVITY: Reaction=1-acyl-2-(9Z)-enoyl-sn-glycero-3-phospholipid + S-adenosyl-L-methionine = 1-acyl-2-(9-cyclopronane)-acyl-sn-glycero-3-phospholipid + H(+) + S-adenosyl-L-homocysteine; Xref=Rhea:RHEA:11988, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:76593, ChEBI:CHEBI:76594; EC=2.1.1.79;--   --1KPI;3HEM;
Q79FX6--Q6MX39--55.2--4.9E-107--umaA Rv0469 LH57_02505----FUNCTION: Methyltransferase that modifies short-chain fatty acids. In vitro, catalyzes the transfer of the methyl group from S-adenosyl-L-methionine (SAM) to the double bond of phospholipid-linked oleic acid to produce tuberculostearic acid (10-methylstearic-acid or TSA). {ECO:0000269|PubMed:23435098}.----   --
Q79FX6--P9WPB1--53.4--1.7E-102--mmaA1 mma1 Rv0645c MTCY20H10.26c--Lipid metabolism; mycolic acid biosynthesis. --FUNCTION: Involved in the conversion of a cis-olefin into a trans-olefin with concomitant introduction of an allylic methyl branch at the proximal position of the precursor to both the methoxy and ketomycolic acids. It directly affects the cis- to trans ratio and indirectly affects the keto to methoxy ratio. {ECO:0000269|PubMed:20472794, ECO:0000269|PubMed:9092547}.----   --
P9WQN9--P9WQN9--100.0--0.0--fbpC mpt45 Rv0129c MTCI5.03c----FUNCTION: The antigen 85 proteins (FbpA, FbpB, FbpC) are responsible for the high affinity of mycobacteria to fibronectin, a large adhesive glycoprotein, which facilitates the attachment of M.tuberculosis to murine alveolar macrophages (AMs). They also help to maintain the integrity of the cell wall by catalyzing the transfer of mycolic acids to cell wall arabinogalactan and through the synthesis of alpha,alpha-trehalose dimycolate (TDM, cord factor). They catalyze the transfer of a mycoloyl residue from one molecule of alpha,alpha-trehalose monomycolate (TMM) to another TMM, leading to the formation of TDM. {ECO:0000269|PubMed:1830294, ECO:0000269|PubMed:9162010}.--CATALYTIC ACTIVITY: Reaction=a 1,2-diacyl-sn-glycerol + an acyl-CoA = a triacyl-sn-glycerol + CoA; Xref=Rhea:RHEA:10868, ChEBI:CHEBI:17815, ChEBI:CHEBI:57287, ChEBI:CHEBI:58342, ChEBI:CHEBI:64615; EC=2.3.1.20; CATALYTIC ACTIVITY: Reaction=2 alpha,alpha'-trehalose 6-mycolate = alpha,alpha'-trehalose 6,6'-bismycolate + alpha,alpha-trehalose; Xref=Rhea:RHEA:23472, ChEBI:CHEBI:16551, ChEBI:CHEBI:18195, ChEBI:CHEBI:18234; EC=2.3.1.122;--   --1DQY;1DQZ;1VA5;3HRH;4MQL;4MQM;4QDO;4QDT;4QDU;4QDX;4QDZ;4QE3;4QEK;5KWI;5KWJ;5OCJ;
P9WQN9--P9WQP3--67.3--1.5E-165--fbpA mpt44 Rv3804c MTV026.09c----FUNCTION: The antigen 85 proteins (FbpA, FbpB, FbpC) are responsible for the high affinity of mycobacteria for fibronectin, a large adhesive glycoprotein, which facilitates the attachment of M.tuberculosis to murine alveolar macrophages (AMs). They also help to maintain the integrity of the cell wall by catalyzing the transfer of mycolic acids to cell wall arabinogalactan, and through the synthesis of alpha,alpha-trehalose dimycolate (TDM, cord factor). They catalyze the transfer of a mycoloyl residue from one molecule of alpha,alpha-trehalose monomycolate (TMM) to another TMM, leading to the formation of TDM. FbpA mediates triacylglycerol (TAG) formation with long-chain acyl-CoA as the acyl donor and 1,2-dipalmitoyl-sn-glycerol (1,2-dipalmitin) as the acyl acceptor. It has a preference for C26:0-CoA over C18:1-CoA. {ECO:0000269|PubMed:12010501, ECO:0000269|PubMed:21819455, ECO:0000269|PubMed:3141278, ECO:0000269|PubMed:9162010}.--CATALYTIC ACTIVITY: Reaction=a 1,2-diacyl-sn-glycerol + an acyl-CoA = a triacyl-sn-glycerol + CoA; Xref=Rhea:RHEA:10868, ChEBI:CHEBI:17815, ChEBI:CHEBI:57287, ChEBI:CHEBI:58342, ChEBI:CHEBI:64615; EC=2.3.1.20; Evidence={ECO:0000269|PubMed:21819455}; CATALYTIC ACTIVITY: Reaction=2 alpha,alpha'-trehalose 6-mycolate = alpha,alpha'-trehalose 6,6'-bismycolate + alpha,alpha-trehalose; Xref=Rhea:RHEA:23472, ChEBI:CHEBI:16551, ChEBI:CHEBI:18195, ChEBI:CHEBI:18234; EC=2.3.1.122; Evidence={ECO:0000269|PubMed:21819455};--   --1SFR;
P9WQN9--P9WQP1--71.6--7.2E-163--fbpB Rv1886c MTCY180.32----FUNCTION: The antigen 85 proteins (FbpA, FbpB, FbpC) are responsible for the high affinity of mycobacteria for fibronectin, a large adhesive glycoprotein, which facilitates the attachment of M.tuberculosis to murine alveolar macrophages (AMs). They also help to maintain the integrity of the cell wall by catalyzing the transfer of mycolic acids to cell wall arabinogalactan and through the synthesis of alpha,alpha-trehalose dimycolate (TDM, cord factor). They catalyze the transfer of a mycoloyl residue from one molecule of alpha,alpha-trehalose monomycolate (TMM) to another TMM, leading to the formation of TDM. {ECO:0000269|PubMed:12010501, ECO:0000269|PubMed:3141278, ECO:0000269|PubMed:9162010}.--CATALYTIC ACTIVITY: Reaction=2 alpha,alpha'-trehalose 6-mycolate = alpha,alpha'-trehalose 6,6'-bismycolate + alpha,alpha-trehalose; Xref=Rhea:RHEA:23472, ChEBI:CHEBI:16551, ChEBI:CHEBI:18195, ChEBI:CHEBI:18234; EC=2.3.1.122; CATALYTIC ACTIVITY: Reaction=a 1,2-diacyl-sn-glycerol + an acyl-CoA = a triacyl-sn-glycerol + CoA; Xref=Rhea:RHEA:10868, ChEBI:CHEBI:17815, ChEBI:CHEBI:57287, ChEBI:CHEBI:58342, ChEBI:CHEBI:64615; EC=2.3.1.20;--   --1F0N;1F0P;5TRZ;5TS1;
P9WQN9--P9WQN7--40.5--8.2E-65--mpt51 fbpC1 fbpD mpb51 Rv3803c MTV026.08c----FUNCTION: May have a role in host tissue attachment, whereby ligands may include the serum protein fibronectin and small sugars. {ECO:0000269|PubMed:14672660}.----   --1R88;
P9WNG3--P9WNG3--100.0--0.0--fabH Rv0533c MTCY25D10.12c--Lipid metabolism; fatty acid biosynthesis. --FUNCTION: Catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. Catalyzes the first condensation reaction which initiates fatty acid synthesis and may therefore play a role in governing the total rate of fatty acid production. Possesses both acetoacetyl-ACP synthase and acetyl transacylase activities. Has some substrate specificity for long chain acyl-CoA such as myristoyl-CoA. Does not use acyl-CoA as primer. Its substrate specificity determines the biosynthesis of mycolic acid fatty acid chain, which is characteristic of mycobacterial cell wall. {ECO:0000269|PubMed:10840036}.--CATALYTIC ACTIVITY: Reaction=acetyl-CoA + H(+) + malonyl-[ACP] = 3-oxobutanoyl-[ACP] + CO2 + CoA; Xref=Rhea:RHEA:12080, Rhea:RHEA-COMP:9623, Rhea:RHEA-COMP:9625, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:78449, ChEBI:CHEBI:78450; EC=2.3.1.180; Evidence={ECO:0000255|HAMAP-Rule:MF_01815};--   --1HZP;1M1M;1U6E;1U6S;2AHB;2AJ9;2QNX;2QNY;2QNZ;2QO0;2QO1;2QX1;
Q9F6D4--P9WNG3--47.0--5.2E-94--fabH Rv0533c MTCY25D10.12c--Lipid metabolism; fatty acid biosynthesis. --FUNCTION: Catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. Catalyzes the first condensation reaction which initiates fatty acid synthesis and may therefore play a role in governing the total rate of fatty acid production. Possesses both acetoacetyl-ACP synthase and acetyl transacylase activities. Has some substrate specificity for long chain acyl-CoA such as myristoyl-CoA. Does not use acyl-CoA as primer. Its substrate specificity determines the biosynthesis of mycolic acid fatty acid chain, which is characteristic of mycobacterial cell wall. {ECO:0000269|PubMed:10840036}.--CATALYTIC ACTIVITY: Reaction=acetyl-CoA + H(+) + malonyl-[ACP] = 3-oxobutanoyl-[ACP] + CO2 + CoA; Xref=Rhea:RHEA:12080, Rhea:RHEA-COMP:9623, Rhea:RHEA-COMP:9625, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:78449, ChEBI:CHEBI:78450; EC=2.3.1.180; Evidence={ECO:0000255|HAMAP-Rule:MF_01815};--   --1HZP;1M1M;1U6E;1U6S;2AHB;2AJ9;2QNX;2QNY;2QNZ;2QO0;2QO1;2QX1;
P9WK83--P9WK83--100.0--4.0E-164--lipB Rv2217 MTCY190.28--Protein modification; protein lipoylation via endogenous pathway; protein N(6)-(lipoyl)lysine from octanoyl-[acyl-carrier-protein]: step 1/2. --FUNCTION: Catalyzes the transfer of endogenously produced octanoic acid from octanoyl-acyl-carrier-protein onto the lipoyl domains of lipoate-dependent enzymes. Lipoyl-ACP can also act as a substrate although octanoyl-ACP is likely to be the physiological substrate. {ECO:0000255|HAMAP-Rule:MF_00013, ECO:0000269|PubMed:16735476}.--CATALYTIC ACTIVITY: Reaction=L-lysyl-[protein] + octanoyl-[ACP] = H(+) + holo-[ACP] + N(6)-octanoyl-L-lysyl-[protein]; Xref=Rhea:RHEA:17665, Rhea:RHEA-COMP:9636, Rhea:RHEA-COMP:9685, Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:9928, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:64479, ChEBI:CHEBI:78463, ChEBI:CHEBI:78809; EC=2.3.1.181; Evidence={ECO:0000255|HAMAP-Rule:MF_00013};--   --1W66;
P9WFF5--P9WFF5--100.0--0.0--Rv1086 MTV017.39----FUNCTION: Catalyzes the condensation of only one isopentenyl pyrophosphate (IPP) unit in the cis configuration to E-geranyl diphosphate (E-GPP) generating the 15 carbon product (2Z,6E)-farnesyl diphosphate (Z-FPP or EZ-FPP). Z-FPP is the precursor of decaprenyl diphosphate, which has a central role in the biosynthesis of the mycobacterial cell wall. {ECO:0000269|PubMed:10816587, ECO:0000269|PubMed:11004176, ECO:0000269|PubMed:11152452}.--CATALYTIC ACTIVITY: Reaction=(2E)-geranyl diphosphate + isopentenyl diphosphate = (2Z,6E)-farnesyl diphosphate + diphosphate; Xref=Rhea:RHEA:23300, ChEBI:CHEBI:33019, ChEBI:CHEBI:58057, ChEBI:CHEBI:128769, ChEBI:CHEBI:162247; EC=2.5.1.68; Evidence={ECO:0000269|PubMed:11004176};--   --2VFW;2VG0;2VG1;
P9WHE9--P9WHE9--100.0--2.4E-108--ribH Rv1416 MTCY21B4.34--Cofactor biosynthesis; riboflavin biosynthesis; riboflavin from 2-hydroxy-3-oxobutyl phosphate and 5-amino-6-(D-ribitylamino)uracil: step 1/2. --FUNCTION: Catalyzes the formation of 6,7-dimethyl-8-ribityllumazine by condensation of 5-amino-6-(D-ribitylamino)uracil with 3,4-dihydroxy-2-butanone 4-phosphate. This is the penultimate step in the biosynthesis of riboflavin. {ECO:0000269|PubMed:15723519}.--CATALYTIC ACTIVITY: Reaction=(2S)-2-hydroxy-3-oxobutyl phosphate + 5-amino-6-(D-ribitylamino)uracil = 6,7-dimethyl-8-(1-D-ribityl)lumazine + H(+) + 2 H2O + phosphate; Xref=Rhea:RHEA:26152, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15934, ChEBI:CHEBI:43474, ChEBI:CHEBI:58201, ChEBI:CHEBI:58830; EC=2.5.1.78;--   --1W19;1W29;2C92;2C94;2C97;2C9B;2C9D;2VI5;
P0A6I3--P9WPA7--52.1--9.1E-109--coaA Rv1092c MTV017.45c--Cofactor biosynthesis; coenzyme A biosynthesis; CoA from (R)-pantothenate: step 1/5. ----CATALYTIC ACTIVITY: Reaction=(R)-pantothenate + ATP = (R)-4'-phosphopantothenate + ADP + H(+); Xref=Rhea:RHEA:16373, ChEBI:CHEBI:10986, ChEBI:CHEBI:15378, ChEBI:CHEBI:29032, ChEBI:CHEBI:30616, ChEBI:CHEBI:456216; EC=2.7.1.33;--   --2GES;2GET;2GEU;2GEV;2ZS7;2ZS8;2ZS9;2ZSA;2ZSB;2ZSD;2ZSE;2ZSF;3AEZ;3AF0;3AF1;3AF2;3AF3;3AF4;3AVO;3AVP;3AVQ;4BFS;4BFT;4BFU;4BFV;4BFW;4BFX;4BFY;4BFZ;5XLV;5XLW;5XMB;
P9WKE1--P9WKE1--100.0--7.3E-150--tmk Rv3247c--Pyrimidine metabolism; dTTP biosynthesis. --FUNCTION: Catalyzes the reversible phosphorylation of deoxythymidine monophosphate (dTMP) to deoxythymidine diphosphate (dTDP), using ATP as its preferred phosphoryl donor. Situated at the junction of both de novo and salvage pathways of deoxythymidine triphosphate (dTTP) synthesis, is essential for DNA synthesis and cellular growth. Has a broad specificity for nucleoside triphosphates, being highly active with ATP or dATP as phosphate donors, and less active with ITP, GTP, CTP and UTP.--CATALYTIC ACTIVITY: Reaction=ATP + dTMP = ADP + dTDP; Xref=Rhea:RHEA:13517, ChEBI:CHEBI:30616, ChEBI:CHEBI:58369, ChEBI:CHEBI:63528, ChEBI:CHEBI:456216; EC=2.7.4.9;--   --1G3U;1GSI;1GTV;1MRN;1MRS;1N5I;1N5J;1N5K;1N5L;1W2G;1W2H;4UNN;4UNP;4UNQ;4UNR;4UNS;5NQ5;5NR7;5NRN;5NRQ;
Q9X1B3--P9WKG9--34.8--4.4E-28--ispD Rv3582c MTCY06G11.29c--Isoprenoid biosynthesis; isopentenyl diphosphate biosynthesis via DXP pathway; isopentenyl diphosphate from 1-deoxy-D-xylulose 5-phosphate: step 2/6. --FUNCTION: Catalyzes the formation of 4-diphosphocytidyl-2-C-methyl-D-erythritol from CTP and 2-C-methyl-D-erythritol 4-phosphate (MEP). {ECO:0000255|HAMAP-Rule:MF_00108}.--CATALYTIC ACTIVITY: Reaction=2-C-methyl-D-erythritol 4-phosphate + CTP + H(+) = 4-CDP-2-C-methyl-D-erythritol + diphosphate; Xref=Rhea:RHEA:13429, ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:37563, ChEBI:CHEBI:57823, ChEBI:CHEBI:58262; EC=2.7.7.60; Evidence={ECO:0000255|HAMAP-Rule:MF_00108};--   --2XWN;3OKR;3Q7U;3Q80;
P9WGV3--P9WGV3--100.0--0.0--ahcY sahH Rv3248c MTCY20B11.23c--Amino-acid biosynthesis; L-homocysteine biosynthesis; L-homocysteine from S-adenosyl-L-homocysteine: step 1/1. --FUNCTION: May play a key role in the regulation of the intracellular concentration of adenosylhomocysteine. {ECO:0000255|HAMAP-Rule:MF_00563}.--CATALYTIC ACTIVITY: Reaction=H2O + S-adenosyl-L-homocysteine = adenosine + L-homocysteine; Xref=Rhea:RHEA:21708, ChEBI:CHEBI:15377, ChEBI:CHEBI:16335, ChEBI:CHEBI:57856, ChEBI:CHEBI:58199; EC=3.3.1.1; Evidence={ECO:0000255|HAMAP-Rule:MF_00563};--   --2ZIZ;2ZJ0;2ZJ1;3CE6;3DHY;
P50250--P9WGV3--56.0--5.1E-180--ahcY sahH Rv3248c MTCY20B11.23c--Amino-acid biosynthesis; L-homocysteine biosynthesis; L-homocysteine from S-adenosyl-L-homocysteine: step 1/1. --FUNCTION: May play a key role in the regulation of the intracellular concentration of adenosylhomocysteine. {ECO:0000255|HAMAP-Rule:MF_00563}.--CATALYTIC ACTIVITY: Reaction=H2O + S-adenosyl-L-homocysteine = adenosine + L-homocysteine; Xref=Rhea:RHEA:21708, ChEBI:CHEBI:15377, ChEBI:CHEBI:16335, ChEBI:CHEBI:57856, ChEBI:CHEBI:58199; EC=3.3.1.1; Evidence={ECO:0000255|HAMAP-Rule:MF_00563};--   --2ZIZ;2ZJ0;2ZJ1;3CE6;3DHY;
P9WNS5--P9WNS5--100.0--2.3E-103--dut Rv2697c MTCY05A6.18c--Pyrimidine metabolism; dUMP biosynthesis; dUMP from dCTP (dUTP route): step 2/2. --FUNCTION: This enzyme is involved in nucleotide metabolism: it produces dUMP, the immediate precursor of thymidine nucleotides and it decreases the intracellular concentration of dUTP so that uracil cannot be incorporated into DNA.--CATALYTIC ACTIVITY: Reaction=dUTP + H2O = diphosphate + dUMP + H(+); Xref=Rhea:RHEA:10248, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:61555, ChEBI:CHEBI:246422; EC=3.6.1.23;--   --1MQ7;1SIX;1SJN;1SLH;1SM8;1SMC;1SNF;2PY4;3H6D;3HZA;3I93;3LOJ;4GCY;5ECT;5EDD;
P0A793--P9WIL3--50.4--1.0E-33--panD Rv3601c MTCY07H7B.21--Cofactor biosynthesis; (R)-pantothenate biosynthesis; beta-alanine from L-aspartate: step 1/1. --FUNCTION: Catalyzes the pyruvoyl-dependent decarboxylation of aspartate to produce beta-alanine. {ECO:0000255|HAMAP-Rule:MF_00446, ECO:0000305|PubMed:12182836}.; FUNCTION: Overexpression of wild-type protein confers resistance to pyrazinoic acid (POA), the active form of the anti-tuberculosis prodrug pyrazinamide (PZA). {ECO:0000269|PubMed:26038753}.--CATALYTIC ACTIVITY: Reaction=H(+) + L-aspartate = beta-alanine + CO2; Xref=Rhea:RHEA:19497, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:29991, ChEBI:CHEBI:57966; EC=4.1.1.11; Evidence={ECO:0000255|HAMAP-Rule:MF_00446, ECO:0000269|PubMed:12182836};--   --2C45;
P9WNP5--P9WNP5--100.0--0.0--menB Rv0548c--Quinol/quinone metabolism; 1,4-dihydroxy-2-naphthoate biosynthesis; 1,4-dihydroxy-2-naphthoate from chorismate: step 6/7. Quinol/quinone metabolism; menaquinone biosynthesis. --FUNCTION: Converts o-succinylbenzoyl-CoA (OSB-CoA) to 1,4-dihydroxy-2-naphthoyl-CoA (DHNA-CoA). {ECO:0000255|HAMAP-Rule:MF_01934, ECO:0000269|PubMed:12909628}.--CATALYTIC ACTIVITY: Reaction=2-succinylbenzoyl-CoA + H(+) = 1,4-dihydroxy-2-naphthoyl-CoA + H2O; Xref=Rhea:RHEA:26562, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:57364, ChEBI:CHEBI:58897; EC=4.1.3.36; Evidence={ECO:0000255|HAMAP-Rule:MF_01934, ECO:0000269|PubMed:12909628, ECO:0000269|PubMed:20643650, ECO:0000269|PubMed:21830810};--   --1Q51;1Q52;1RJM;1RJN;3T8A;3T8B;4QII;4QIJ;
P9WPX7--P9WPX7--100.0--3.7E-99--aroQ aroD Rv2537c MTCY159.19--Metabolic intermediate biosynthesis; chorismate biosynthesis; chorismate from D-erythrose 4-phosphate and phosphoenolpyruvate: step 3/7. --FUNCTION: Catalyzes a trans-dehydration via an enolate intermediate. {ECO:0000250}.--CATALYTIC ACTIVITY: Reaction=3-dehydroquinate = 3-dehydroshikimate + H2O; Xref=Rhea:RHEA:21096, ChEBI:CHEBI:15377, ChEBI:CHEBI:16630, ChEBI:CHEBI:32364; EC=4.2.1.10;--   --1H05;1H0R;1H0S;2DHQ;2XB8;2Y71;2Y76;2Y77;3N59;3N76;3N7A;3N86;3N87;3N8K;3N8N;4B6O;4B6P;4B6Q;4CIV;4CIW;4CIX;4CIY;4CKW;4CKX;4CKY;4CKZ;4CL0;4KI7;4KIJ;4KIU;4KIW;4V0S;
Q47Q21--P9WJP3--51.3--5.2E-86--menC Rv0553 MTCY25D10.32--Quinol/quinone metabolism; 1,4-dihydroxy-2-naphthoate biosynthesis; 1,4-dihydroxy-2-naphthoate from chorismate: step 4/7. Quinol/quinone metabolism; menaquinone biosynthesis. --FUNCTION: Converts 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate (SHCHC) to 2-succinylbenzoate (OSB). {ECO:0000255|HAMAP-Rule:MF_00470}.--CATALYTIC ACTIVITY: Reaction=(1R,6R)-6-hydroxy-2-succinyl-cyclohexa-2,4-diene-1-carboxylate = 2-succinylbenzoate + H2O; Xref=Rhea:RHEA:10196, ChEBI:CHEBI:15377, ChEBI:CHEBI:18325, ChEBI:CHEBI:58689; EC=4.2.1.113; Evidence={ECO:0000255|HAMAP-Rule:MF_00470};--   --
A0R559--P9WKG5--76.0--4.0E-78--ispF Rv3581c MTCY06G11.28c--Isoprenoid biosynthesis; isopentenyl diphosphate biosynthesis via DXP pathway; isopentenyl diphosphate from 1-deoxy-D-xylulose 5-phosphate: step 4/6. --FUNCTION: Involved in the biosynthesis of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), two major building blocks of isoprenoid compounds. Catalyzes the conversion of 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate (CDP-ME2P) to 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (ME-CPP) with a corresponding release of cytidine 5-monophosphate (CMP). {ECO:0000269|PubMed:20189102}.--CATALYTIC ACTIVITY: Reaction=4-CDP-2-C-methyl-D-erythritol 2-phosphate = 2-C-methyl-D-erythritol 2,4-cyclic diphosphate + CMP; Xref=Rhea:RHEA:23864, ChEBI:CHEBI:57919, ChEBI:CHEBI:58483, ChEBI:CHEBI:60377; EC=4.6.1.12; Evidence={ECO:0000269|PubMed:20189102};--   --
P32396--P9WNE3--30.2--2.6E-34--hemH hemZ Rv1485 MTCY277.06--Porphyrin-containing compound metabolism; protoheme biosynthesis; protoheme from protoporphyrin-IX: step 1/1. --FUNCTION: Involved in the biosynthesis of heme. Catalyzes the ferrous insertion into protoporphyrin IX to form protoheme. {ECO:0000269|PubMed:11948160, ECO:0000269|PubMed:15850757}.--CATALYTIC ACTIVITY: Reaction=2 H(+) + heme b = Fe(2+) + protoporphyrin IX; Xref=Rhea:RHEA:22584, ChEBI:CHEBI:15378, ChEBI:CHEBI:29033, ChEBI:CHEBI:57306, ChEBI:CHEBI:60344; EC=4.99.1.1;--   --
P9WH11--P9WH11--100.0--2.8E-148--rmlC strM Rv3465--Carbohydrate biosynthesis; dTDP-L-rhamnose biosynthesis. --FUNCTION: Catalyzes the epimerization of the C3' and C5'positions of dTDP-6-deoxy-D-xylo-4-hexulose, forming dTDP-6-deoxy-L-lyxo-4-hexulose. Involved in the biosynthesis of the dTDP-L-rhamnose which is a component of the critical linker, D-N-acetylglucosamine-L-rhamnose disaccharide, which connects the galactan region of arabinogalactan to peptidoglycan via a phosphodiester linkage. {ECO:0000269|PubMed:16472764}.--CATALYTIC ACTIVITY: Reaction=dTDP-4-dehydro-6-deoxy-alpha-D-glucose = dTDP-4-dehydro-beta-L-rhamnose; Xref=Rhea:RHEA:16969, ChEBI:CHEBI:57649, ChEBI:CHEBI:62830; EC=5.1.3.13; Evidence={ECO:0000269|PubMed:16472764};--   --1PM7;1UPI;2IXC;
Q46822--P9WKK5--46.9--6.9E-40--idi Rv1745c MTCY04C12.29c MTCY28.08c--Isoprenoid biosynthesis; dimethylallyl diphosphate biosynthesis; dimethylallyl diphosphate from isopentenyl diphosphate: step 1/1. --FUNCTION: Catalyzes the 1,3-allylic rearrangement of the homoallylic substrate isopentenyl (IPP) to its highly electrophilic allylic isomer, dimethylallyl diphosphate (DMAPP). {ECO:0000255|HAMAP-Rule:MF_00202}.--CATALYTIC ACTIVITY: Reaction=isopentenyl diphosphate = dimethylallyl diphosphate; Xref=Rhea:RHEA:23284, ChEBI:CHEBI:57623, ChEBI:CHEBI:128769; EC=5.3.3.2; Evidence={ECO:0000255|HAMAP-Rule:MF_00202};--   --
P37747--P9WIQ1--43.5--6.6E-102--glf Rv3809c--Cell wall biogenesis; cell wall polysaccharide biosynthesis. --FUNCTION: Catalyzes the interconversion through a 2-keto intermediate of uridine diphosphogalactopyranose (UDP-GalP) into uridine diphosphogalactofuranose (UDP-GalF) which is a key building block for cell wall construction in Mycobacterium tuberculosis. {ECO:0000269|PubMed:9692181}.--CATALYTIC ACTIVITY: Reaction=UDP-alpha-D-galactose = UDP-alpha-D-galactofuranose; Xref=Rhea:RHEA:24132, ChEBI:CHEBI:66914, ChEBI:CHEBI:66915; EC=5.4.99.9;--   --1V0J;4RPG;4RPH;4RPJ;4RPK;4RPL;
P9WIQ1--P9WIQ1--100.0--0.0--glf Rv3809c--Cell wall biogenesis; cell wall polysaccharide biosynthesis. --FUNCTION: Catalyzes the interconversion through a 2-keto intermediate of uridine diphosphogalactopyranose (UDP-GalP) into uridine diphosphogalactofuranose (UDP-GalF) which is a key building block for cell wall construction in Mycobacterium tuberculosis. {ECO:0000269|PubMed:9692181}.--CATALYTIC ACTIVITY: Reaction=UDP-alpha-D-galactose = UDP-alpha-D-galactofuranose; Xref=Rhea:RHEA:24132, ChEBI:CHEBI:66914, ChEBI:CHEBI:66915; EC=5.4.99.9;--   --1V0J;4RPG;4RPH;4RPJ;4RPK;4RPL;
P9WN39--P9WN39--100.0--0.0--glnA1 glnA Rv2220 MTCY190.31 MTCY427.01----FUNCTION: Involved in nitrogen metabolism via ammonium assimilation. Catalyzes the ATP-dependent biosynthesis of glutamine from glutamate and ammonia (PubMed:7937767, PubMed:12819079). Also able to use GTP (PubMed:7937767). D-glutamate is a poor substrate, and DL-glutamate shows about 50% of the standard specific activity (PubMed:7937767). Also plays a key role in controlling the ammonia levels within infected host cells and so contributes to the pathogens capacity to inhibit phagosome acidification and phagosome-lysosome fusion (PubMed:7937767, PubMed:12819079). Involved in cell wall biosynthesis via the production of the major component poly-L-glutamine (PLG) (PubMed:7937767, PubMed:10618433). PLG synthesis in the cell wall occurs only in nitrogen limiting conditions and on the contrary high nitrogen conditions inhibit PLG synthesis (Probable). {ECO:0000269|PubMed:10618433, ECO:0000269|PubMed:12819079, ECO:0000269|PubMed:7937767, ECO:0000305|PubMed:9278431}.--CATALYTIC ACTIVITY: Reaction=ATP + L-glutamate + NH4(+) = ADP + H(+) + L-glutamine + phosphate; Xref=Rhea:RHEA:16169, ChEBI:CHEBI:15378, ChEBI:CHEBI:28938, ChEBI:CHEBI:29985, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:58359, ChEBI:CHEBI:456216; EC=6.3.1.2; Evidence={ECO:0000269|PubMed:7937767, ECO:0000305|PubMed:19695264};--   --1HTO;1HTQ;2BVC;2WGS;2WHI;3ZXR;3ZXV;4ACF;4XYC;
P9WIL5--P9WIL5--100.0--0.0--panC Rv3602c MTCY07H7B.20--Cofactor biosynthesis; (R)-pantothenate biosynthesis; (R)-pantothenate from (R)-pantoate and beta-alanine: step 1/1. --FUNCTION: Catalyzes the condensation of pantoate with beta-alanine in an ATP-dependent reaction via a pantoyl-adenylate intermediate. {ECO:0000269|PubMed:11669627}.--CATALYTIC ACTIVITY: Reaction=(R)-pantoate + ATP + beta-alanine = (R)-pantothenate + AMP + diphosphate + H(+); Xref=Rhea:RHEA:10912, ChEBI:CHEBI:15378, ChEBI:CHEBI:15980, ChEBI:CHEBI:29032, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57966, ChEBI:CHEBI:456215; EC=6.3.2.1; Evidence={ECO:0000269|PubMed:12717031};--   --1MOP;1N2B;1N2E;1N2G;1N2H;1N2I;1N2J;1N2O;2A7X;2A84;2A86;2A88;3COV;3COW;3COY;3COZ;3IMC;3IME;3IMG;3IOB;3IOC;3IOD;3IOE;3ISJ;3IUB;3IUE;3IVC;3IVG;3IVX;3LE8;4DDH;4DDK;4DDM;4DE5;4EF6;4EFK;4FZJ;4G5F;4G5Y;
